Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Arthritis Research & Therapy
|
September 5, 2008
Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome
Dina Dadabhoy, Leslie J Crofford, Michael Spaeth, et al.
International Journal of General Medicine
|
April 30, 2010
A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia
Amy S Chappell, Laurence A Bradley, Curtis Wiltse, et al.
Arthritis Research & Therapy
|
November 30, 2013
Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia
Michael Spaeth, Cayetano Alegre, Serge Perrot, et al.
Journal of Clinical Medicine
|
March 6, 2019
Superiority of a Treat-to-Target Strategy over Conventional Treatment with Fixed csDMARD and Corticosteroids: A Multi-Center Randomized Controlled Trial in RA Patients with an Inadequate Response to Conventional Synthetic DMARDs, and New Therapy with Certolizumab Pegol
Ruediger B Mueller, Michael Spaeth, Cord von Restorff, et al.
Annals of the Rheumatic Diseases
|
February 2, 2012
Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial
Michael Spaeth, Robert M Bennett, Beverly A Benson, et al.
Clinical Therapeutics
|
March 17, 2012
Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine
Robert Bennett, I Jon Russell, Ernest Choy, et al.
Clinical Rheumatology
|
November 14, 2016
Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM)
Ruediger B Mueller, Nazim Reshiti, Toni Kaegi, et al.
Arthritis Care & Research
|
February 12, 2011
Estimation of minimum clinically important difference for pain in fibromyalgia
Philip J Mease, Michael Spaeth, Daniel J Clauw, et al.
Health and Quality of Life Outcomes
|
October 25, 2014
Improving the primary care physicians' decision making for fibromyalgia in clinical practice: development and validation of the Fibromyalgia Detection (FibroDetect®) screening tool
Ralf Baron, Serge Perrot, Isabelle Guillemin, et al.
Seminars in Arthritis and Rheumatism
|
March 3, 2009
Prevalence of fibromyalgia: a survey in five European countries
Jaime C Branco, Bernard Bannwarth, Inmaculada Failde, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Arthritis Research & Therapy
|
September 5, 2008
Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome
Dina Dadabhoy, Leslie J Crofford, Michael Spaeth, et al.
International Journal of General Medicine
|
April 30, 2010
A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia
Amy S Chappell, Laurence A Bradley, Curtis Wiltse, et al.
Arthritis Research & Therapy
|
November 30, 2013
Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia
Michael Spaeth, Cayetano Alegre, Serge Perrot, et al.
Journal of Clinical Medicine
|
March 6, 2019
Superiority of a Treat-to-Target Strategy over Conventional Treatment with Fixed csDMARD and Corticosteroids: A Multi-Center Randomized Controlled Trial in RA Patients with an Inadequate Response to Conventional Synthetic DMARDs, and New Therapy with Certolizumab Pegol
Ruediger B Mueller, Michael Spaeth, Cord von Restorff, et al.
Annals of the Rheumatic Diseases
|
February 2, 2012
Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial
Michael Spaeth, Robert M Bennett, Beverly A Benson, et al.
Clinical Therapeutics
|
March 17, 2012
Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine
Robert Bennett, I Jon Russell, Ernest Choy, et al.
Clinical Rheumatology
|
November 14, 2016
Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM)
Ruediger B Mueller, Nazim Reshiti, Toni Kaegi, et al.
Arthritis Care & Research
|
February 12, 2011
Estimation of minimum clinically important difference for pain in fibromyalgia
Philip J Mease, Michael Spaeth, Daniel J Clauw, et al.
Health and Quality of Life Outcomes
|
October 25, 2014
Improving the primary care physicians' decision making for fibromyalgia in clinical practice: development and validation of the Fibromyalgia Detection (FibroDetect®) screening tool
Ralf Baron, Serge Perrot, Isabelle Guillemin, et al.
Seminars in Arthritis and Rheumatism
|
March 3, 2009
Prevalence of fibromyalgia: a survey in five European countries
Jaime C Branco, Bernard Bannwarth, Inmaculada Failde, et al.
Page
of 3